Kalaris Therapeutics Inc (KLRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 201,661 | 243,187 | 225,447 | 168,645 | 122,661 |
| Marketable Securities | 46,459 | 32,654 | 87,890 | 168,347 | 233,663 |
| Receivables | 50 | N/A | N/A | N/A | N/A |
| Other current assets | 0 | 151 | 409 | 469 | 450 |
| TOTAL | $253,348 | $281,872 | $316,045 | $339,664 | $361,317 |
| Non-Current Assets | |||||
| PPE Net | 1,549 | 1,113 | 1,215 | 869 | 812 |
| Other Non-Current Assets | 31,697 | 33,545 | 10,251 | 10,748 | 8,692 |
| TOTAL | $33,246 | $34,658 | $11,466 | $11,617 | $9,504 |
| Total Assets | $286,594 | $316,530 | $327,511 | $351,281 | $370,821 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,361 | 133 | 4,202 | 2,057 | 963 |
| Accrued Expenses | 20,152 | 15,798 | 9,975 | 7,879 | 7,530 |
| Other current liabilities | 1,742 | 1,945 | 1,701 | 779 | 572 |
| TOTAL | $37,853 | $24,173 | $20,708 | $15,500 | $12,294 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 23,475 | 25,053 | 4,334 | 5,412 | 5,463 |
| TOTAL | $23,475 | $25,053 | $4,334 | $5,412 | $5,463 |
| Total Liabilities | $61,328 | $49,226 | $25,042 | $20,912 | $17,757 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,843 | 2,834 | 2,833 | 2,832 | 2,832 |
| Common Shares | 7 | 7 | 7 | 7 | 7 |
| Retained earnings | -297,065 | -239,124 | -193,614 | -156,026 | -125,103 |
| Other shareholders' equity | -155 | -133 | -25 | 13 | -112 |
| TOTAL | $225,266 | $267,304 | $302,469 | $330,369 | $353,064 |
| Total Liabilities And Equity | $286,594 | $316,530 | $327,511 | $351,281 | $370,821 |